1Karat C, Madhivanan P, Krupp K. The clinical and microbiological correlates of premature rupture of membranes[J]. Indian J Med Microbiol,2006 Oct,24(4) :283 -5.
2Robert V, Hideaki N. Matrix metalloproteinases and tissue inhibitors of metallopreteinases - structure, function, and biochemistry [ J ]. Circulation Research, 2003,92 ( 8 ) : 827 - 839.
3Wilson SR, Gallagher S, Warpeha K, et al. Amplification of MMP - 9 and MMP- 2 production by prostate cancer cell lines via activation of protease - activated receptors [ J ]. Prostate,2004, 60 (2) : 168.
4Shubayev VI, Myers RR. Matrix metalloproteinase 9 promotes nerve growth- induced neurite elongation but not new sprout fomation in vitro[J]. J Neurosci Res, 2004, 77(2):229-239.
5Dechow TN,et al. Requirement of matrix metalloproteinase - 9for the transform of human mammary epithelial cells by Star.3 - C [ J ]. Proc Natl Acad Sci USA, 2004,101 (29) :10602 -10607.
6Renko Kalela A, Jaakkola O, et al. Serum matrix metalloproteinase -9 is elsvated in menwith a history of myocardial infaretion [ J ]. Seand J Clin Lab Invest, 2004, 64(3) :255 -61.
7Giannelli G, Erriquez R, iannone F, et al. MMP-2, MMP-9, TIMP- 1 and TIMP- 2 levels in patients with rheumatoid arthritis and psoriatic arthritis [J]. Clin Exp Rheumatol,2004, 22(3) :335.
8Kuyvenhoven JP, Verspaget HW, Gao Q, et al . Assessment of serum matrix metalloproteinases MMP - 2 and MMP - 9 after human liver transplantstion: increased serum MMP- 9 level in acute rejiction [ J ]. Transplant, 2004, 77 ( 11 ) : 1646 - 52.
9Mukhopadhyay S, Minshi HG, Kambhampati S, et al. Calcium induced matrix metalloproteinase - 9 gene expression is differentially regulated by ERK1/2 and p38MAPK in oral keratinocytes and oral squam ous cell carcinoma[J]. J Biol Chem,2004,79(32) :33139.
10Chebassier N,et al. In vitro induction of matrix metalloproteinase - 9 and atrix metalloproteinase- 2 expression in kerstinocytes by boron and manganese[J]. Exp Dermatol, 2004, 13(8) :484 -90.
二级参考文献14
1Newton ER.Chorioamnionitis and intra-amniotic infection[J].Clin Obstet Gynecol,1993,36 (4):795-808.
2Saji F,Samejima Y,Kamiura S,et al.Cytokine production in chorioamnionitis[J].J Reprod Immunol,2000,47(2):185-196.
3Strongin AY,Collier I,Bannikov G,et al.Mechanism of cell surface activation of 72-kDatype Ⅳ collagenase[J].J Biol Chem,1995,270(10):5331-5338.
4Locksmith CI,Clark P,Duff P,et al.Amniotic fluid matrix met alloproteinase-9 levels in women with preterm labor and suspected intra-amniotic infection[J].Obstet Gynecol J,1999,94(1):1-6.
5Hao X P, Willis J E, Pretlow T G, ctal. Loss of Fragile histidine triad expression in colorectal carcinomas and premalignant lesions[J]. Cancer Res, 2000, 60 ( 1 ) : 18
6Liotta L A, Kohn E C. The microenvironment of the tumor-host interface[J]. Nature, 2001, 411(6835):375
7Malak T M, Ockleford C D, Bell S C, et al. Confocal immunofluorescence localization of collagen types Ⅰ,Ⅲ,Ⅳ,Ⅵ and their ultrastructural organization in term human fetal membranes[J]. Placenta, 1993, 14(4):385
8Mclaren J ,Taylor D J, Bell S C. Increased concentration of promatrix metalloprotienase 9 in term fetal membranes overlying the cervix before labo[J]. Am J Obstet Gynecol, 2000, 182(2):409
9Maj J G, Kankofer M. Activity of 72-kDa and 92-kDa matrix metalloproteinases in placental tissues of cows with and without retained fetal membranes[J]. Placenta, 1997, 18(8):683
10Locksmith G J, Clark P, Duff P, et al. Amniotic fluid concentrations of matrix metalloproteinase 9 and tissue inhibitor of metalloproteinase 1 during pregnancy and labor[J].Am J Obstet Gynecol, 2001,184(2) :159
3Sheu JR,Fong TH,Liu CM,et al.ExPression of matrik metallicProteinase-9 in human Platelets [J].Br JPH Armacol,2004,60 (2):168-174.
4Wilson SR,Gallagher S,WarPeha K, et al.Amplification of MMP-2 andMMP-9 Production byProstate cancer cell lines viaac-tivation ofProtease-activated recePtors[J].Prostate,2004,60(2): 168-174.
